These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 34377596)

  • 61. Prognostic value of derived neutrophil-to-lymphocyte ratio (dNLR) in patients with non-small cell lung cancer receiving immune checkpoint inhibitors: a meta-analysis.
    Yang T; Hao L; Yang X; Luo C; Wang G; Lin Cai C; Qi S; Li Z
    BMJ Open; 2021 Sep; 11(9):e049123. PubMed ID: 34475167
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Impact of concomitant medication use and immune-related adverse events on response to immune checkpoint inhibitors.
    Gandhi S; Pandey M; Ammannagari N; Wang C; Bucsek MJ; Hamad L; Repasky E; Ernstoff MS
    Immunotherapy; 2020 Feb; 12(2):141-149. PubMed ID: 32064978
    [No Abstract]   [Full Text] [Related]  

  • 63. Metformin in the prevention of hepatocellular carcinoma in diabetic patients: A systematic review.
    Cunha V; Cotrim HP; Rocha R; Carvalho K; Lins-Kusterer L
    Ann Hepatol; 2020; 19(3):232-237. PubMed ID: 31836424
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Aspirin, metformin, and statin use on the risk of gastric cancer: A nationwide population-based cohort study in Korea with systematic review and meta-analysis.
    Seo SI; Park CH; Kim TJ; Bang CS; Kim JY; Lee KJ; Kim J; Kim HH; You SC; Shin WG
    Cancer Med; 2022 Feb; 11(4):1217-1231. PubMed ID: 34970858
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Maintenance use of aspirin or other non-steroidal anti-inflammatory drugs (NSAIDs) and prostate cancer risk.
    Ma Y; Brusselaers N
    Prostate Cancer Prostatic Dis; 2018 Apr; 21(1):147-152. PubMed ID: 29259292
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Efficacy and safety of immune checkpoint inhibitors in patients with advanced non-small cell lung cancer (NSCLC): a systematic literature review.
    Wagner G; Stollenwerk HK; Klerings I; Pecherstorfer M; Gartlehner G; Singer J
    Oncoimmunology; 2020 Jun; 9(1):1774314. PubMed ID: 32923134
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Systematic review with meta-analysis: the gastrointestinal benefits of COX-2 selective inhibitors with concomitant use of low-dose aspirin.
    Yuan JQ; Yang M; Threapleton DE; Qi XS; Ye DQ; Mao C; Tang JL; Higgins JP
    Aliment Pharmacol Ther; 2016 Oct; 44(8):785-95. PubMed ID: 27534608
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Anti-PD-1/L1-associated immune-related adverse events as harbinger of favorable clinical outcome: systematic review and meta-analysis.
    Park R; Lopes L; Saeed A
    Clin Transl Oncol; 2021 Jan; 23(1):100-109. PubMed ID: 32495269
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Common medications and prostate cancer mortality: a review.
    Stopsack KH; Greenberg AJ; Mucci LA
    World J Urol; 2017 Jun; 35(6):875-882. PubMed ID: 27492013
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Population-wide impacts of aspirin, statins, and metformin use on prostate cancer incidence and mortality.
    Koo HY; Jeong SM; Cho MH; Chun S; Shin DW; Park J
    Sci Rep; 2021 Aug; 11(1):16171. PubMed ID: 34373584
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Evaluation of preventive cardiovascular pharmacotherapy after coronary artery bypass graft surgery.
    Barry AR; Koshman SL; Norris CM; Ross DB; Pearson GJ
    Pharmacotherapy; 2014 May; 34(5):464-72. PubMed ID: 24877186
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Aspirin and non-steroidal anti-inflammatory drugs use reduce gastric cancer risk: A dose-response meta-analysis.
    Huang XZ; Chen Y; Wu J; Zhang X; Wu CC; Zhang CY; Sun SS; Chen WJ
    Oncotarget; 2017 Jan; 8(3):4781-4795. PubMed ID: 27902474
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Impact of antibiotic use and other concomitant medications on the efficacy of immune checkpoint inhibitors in patients with advanced cancer.
    Iglesias-Santamaría A
    Clin Transl Oncol; 2020 Sep; 22(9):1481-1490. PubMed ID: 31919759
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Additional Benefits of Routine Drugs on Gastrointestinal Cancer: Statins, Metformin, and Proton Pump Inhibitors.
    Joo MK; Park JJ; Chun HJ
    Dig Dis; 2018; 36(1):1-14. PubMed ID: 28881340
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Are COX-2 inhibitors preferable to non-selective non-steroidal anti-inflammatory drugs in patients with risk of cardiovascular events taking low-dose aspirin?
    Strand V
    Lancet; 2007 Dec; 370(9605):2138-51. PubMed ID: 18156036
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Systematic review of β blocker, aspirin, and statin in critically ill patients: importance of severity of illness and cardiac troponin.
    Rothenberg FG; Clay MB; Jamali H; Vandivier-Pletsch RH
    J Investig Med; 2017 Apr; 65(4):747-753. PubMed ID: 28138011
    [TBL] [Abstract][Full Text] [Related]  

  • 77. New drug candidates for bipolar disorder-A nation-wide population-based study.
    Kessing LV; Rytgaard HC; Gerds TA; Berk M; Ekstrøm CT; Andersen PK
    Bipolar Disord; 2019 Aug; 21(5):410-418. PubMed ID: 30873730
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Survival of Patients Treated with Antibiotics and Immunotherapy for Cancer: A Systematic Review and Meta-Analysis.
    Petrelli F; Iaculli A; Signorelli D; Ghidini A; Dottorini L; Perego G; Ghidini M; Zaniboni A; Gori S; Inno A
    J Clin Med; 2020 May; 9(5):. PubMed ID: 32414103
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Adverse impact of bone metastases on clinical outcomes of patients with advanced non-small cell lung cancer treated with immune checkpoint inhibitors.
    Li X; Wang L; Chen S; Zhou F; Zhao J; Zhao W; Su C
    Thorac Cancer; 2020 Oct; 11(10):2812-2819. PubMed ID: 32779372
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Inferring the role of the microbiome on survival in patients treated with immune checkpoint inhibitors: causal modeling, timing, and classes of concomitant medications.
    Spakowicz D; Hoyd R; Muniak M; Husain M; Bassett JS; Wang L; Tinoco G; Patel SH; Burkart J; Miah A; Li M; Johns A; Grogan M; Carbone DP; Verschraegen CF; Kendra KL; Otterson GA; Li L; Presley CJ; Owen DH
    BMC Cancer; 2020 May; 20(1):383. PubMed ID: 32375706
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.